Survival of Older Patients With Cancer in the Veterans Health Administration Versus Fee-for-Service Medicare

被引:71
作者
Landrum, Mary Beth [1 ]
Keating, Nancy L. [2 ]
Lamont, Elizabeth B. [3 ]
Bozeman, Samuel R. [5 ]
Krasnow, Steven H. [6 ]
Shulman, Lawrence [4 ]
Brown, Jennifer R. [4 ]
Earle, Craig C. [7 ]
Rabin, Michael [4 ]
McNeil, Barbara J. [2 ]
机构
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] ABT Associates Inc, Cambridge, MA 02138 USA
[6] DC Vet Affairs Med Ctr, Washington, DC USA
[7] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
关键词
CELL LUNG-CANCER; QUALITY-OF-CARE; COLORECTAL-CANCER; MYOCARDIAL-INFARCTION; PROPENSITY SCORE; ADVERSE EVENTS; AFFAIRS; CHEMOTHERAPY; SYSTEM; COMORBIDITY;
D O I
10.1200/JCO.2011.35.6758
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The Veterans Health Administration (VHA) provides high-quality preventive chronic care and cancer care, but few studies have documented improved patient outcomes that result from this high-quality care. We compared the survival rates of older patients with cancer in the VHA and fee-for-service (FFS) Medicare and examined whether differences in the stage at diagnosis, receipt of guideline-recommended therapies, and unmeasured characteristics explain survival differences. Patients and Methods We used propensity-score methods to compare all-cause and cancer-specific survival rates for men older than age 65 years who were diagnosed or received their first course of treatment for colorectal, lung, lymphoma, or multiple myeloma in VHA hospitals from 2001 to 2004 to similar FFS-Medicare enrollees diagnosed in Surveillance, Epidemiology, and End Results (SEER) areas in the same time frame. We examined the role of unmeasured factors by using sensitivity analyses. Results VHA patients versus similar FFS SEER-Medicare patients had higher survival rates of colon cancer (adjusted hazard ratio [HR], 0.87; 95% CI, 0.82 to 0.93) and non-small-cell lung cancer (NSCLC; HR, 0.91; 95% CI, 0.88 to 0.95) and similar survival rates of rectal cancer (HR, 1.05; 95% CI, 0.95 to 1.16), small-cell lung cancer (HR, 0.99; 95% CI, 0.93 to 1.05), diffuse large-B-cell lymphoma (HR, 1.02; 95% CI, 0.89 to 1.18), and multiple myeloma (HR, 0.92; 95% CI, 0.83 to 1.03). The diagnosis of VHA patients at earlier stages explained much of the survival advantages for colon cancer and NSCLC. Sensitivity analyses suggested that additional adjustment for the severity of comorbid disease or performance status could have substantial effects on estimated differences. Conclusion The survival rate for older men with cancer in the VHA was better than or equivalent to the survival rate for similar FFS-Medicare beneficiaries. The VHA provision of high-quality care, particularly preventive care, can result in improved patient outcomes.
引用
收藏
页码:1072 / 1079
页数:8
相关论文
共 40 条
  • [1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [2] Are patients at veterans affairs medical centers sicker?: A comparative analysis of health status and medical resource use
    Agha, Z
    Lofgren, RP
    VanRuiswyk, JV
    Layde, PM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) : 3252 - 3257
  • [3] American Joint Committee on Cancer, COLL STAG DAT COLL S
  • [4] Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample
    Asch, SM
    McGlynn, EA
    Hogan, MM
    Hayward, RA
    Shekelle, P
    Rubenstein, L
    Keesey, J
    Adams, J
    Kerr, EA
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 141 (12) : 938 - 945
  • [5] Hospital use and survival among Veterans Affairs beneficiaries
    Ashton, CM
    Souchek, J
    Petersen, NJ
    Menke, TJ
    Collins, TC
    Kizer, KW
    Wright, SM
    Wray, NP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) : 1637 - 1646
  • [6] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [7] Adverse Events Among the Elderly Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer
    Chrischilles, Elizabeth A.
    Pendergast, Jane F.
    Kahn, Katherine L.
    Wallace, Robert B.
    Moga, Daniela C.
    Harrington, David P.
    Kiefe, Catarina I.
    Weeks, Jane C.
    West, Dee W.
    Zafar, S. Yousuf
    Fletcher, Robert H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 620 - 627
  • [8] D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
  • [9] 2-B
  • [10] COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA
    FISHER, RI
    GAYNOR, ER
    DAHLBERG, S
    OKEN, MM
    GROGAN, TM
    MIZE, EM
    GLICK, JH
    COLTMAN, CA
    MILLER, TP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) : 1002 - 1006